Synthesis of a mol. with impartial biol. activities against an explicit objective is always a demanding task.We herein report the synthesis, DFT calculation and biol. activities of novel 3-(4-substituted phenyl)-7-methyl-6-(pyridin-4-yl)-7H-[1,2,4]triazolo[4,3-b][1,2,4]triazole by making use of isoniazide.Structure conformations all these novel compounds were analyzed by using FTIR, NMR (1H, and 13C), mass and elemental anal.The DFT calculations were analyzed for the selected compounds by applying the DFT/B3LYP/6-311++G(d, p) method.The drug-likeness predictions were disclosed for the synthesized compoundsThe in vitro biol. activities were disclosed for all the novel compoundsAmongst, the compound 7-methyl-3-(4-nitro phenyl)-6-(pyridin-4-yl)-7H-[1,2,4]triazolo[4,3-b][1,2,4]triazole showed excellent biol. activity with IC50 value 10.21± 0.80μg/mL, 10.21± 0.42μg/mL, and 20.46± 0.05μg/mL for anti-TB, antioxidant and antidiabetic activities resp.Further, the synthesized compounds were taken for the in silico mol. modeling against mycobacterium tuberculosis enoyl reductase (INHA) (PDB ID: 4TZK), cytochrome c peroxidase (PDB id: 2x08), and Human maltase-glucoamylase (PDB: 2QMJ).